Commentary on the coronavirus pandemic: Anticipating a fourth wave in the opioid epidemic
- PMID: 32496102
- DOI: 10.1037/tra0000622
Commentary on the coronavirus pandemic: Anticipating a fourth wave in the opioid epidemic
Abstract
Experiencing the COVID-19 pandemic simultaneously with the U.S. opioid epidemic is anticipated to have a profound mental health impact on some of our most vulnerable populations. Recent federal and state regulatory changes have been made under the state of emergency in order to ameliorate the some of the challenges faced in maintaining access to substance use and addiction services during such times. There are currently considerable limitations in quantifying the impact of COVID-19 among those with substance use disorders, however, it is imperative that health care systems continue to serve this population in order to prevent associated morbidity and mortality. (PsycInfo Database Record (c) 2020 APA, all rights reserved).
Similar articles
-
COVID-19, mental health, and opioid use disorder: Old and new public health crises intertwine.Psychol Trauma. 2020 Aug;12(S1):S111-S112. doi: 10.1037/tra0000660. Epub 2020 Jun 18. Psychol Trauma. 2020. PMID: 32551759 Free PMC article.
-
Opioids: The Forgotten Epidemic?Tex Med. 2020 Oct 1;116(10):32-35. Tex Med. 2020. PMID: 33126270
-
COVID-19 and U.S.-based refugee populations: Commentary.Psychol Trauma. 2020 Aug;12(S1):S228-S229. doi: 10.1037/tra0000602. Epub 2020 Jun 15. Psychol Trauma. 2020. PMID: 32538665
-
A health crisis within a health crisis: Opioid access in the COVID-19 pandemic.Subst Abus. 2021;42(2):148-152. doi: 10.1080/08897077.2021.1900981. Epub 2021 Apr 13. Subst Abus. 2021. PMID: 33849399 Review.
-
Maintaining treatment and prevention programs for opioid use disorders during the coronavirus disease 2019 pandemic.Curr Opin Psychiatry. 2021 Jul 1;34(4):369-375. doi: 10.1097/YCO.0000000000000708. Curr Opin Psychiatry. 2021. PMID: 33859127 Free PMC article. Review.
Cited by
-
Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update.Expert Opin Pharmacother. 2022 Nov;23(16):1819-1830. doi: 10.1080/14656566.2022.2140039. Epub 2022 Nov 14. Expert Opin Pharmacother. 2022. PMID: 36278879 Free PMC article. Review.
-
Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach.Front Psychiatry. 2021 Feb 9;11:632405. doi: 10.3389/fpsyt.2020.632405. eCollection 2020. Front Psychiatry. 2021. PMID: 33633599 Free PMC article.
-
Technology-assisted methadone take-home dosing for dispensing methadone to persons with opioid use disorder during the Covid-19 pandemic.J Subst Abuse Treat. 2021 Feb;121:108197. doi: 10.1016/j.jsat.2020.108197. Epub 2020 Nov 24. J Subst Abuse Treat. 2021. PMID: 33357606 Free PMC article. Clinical Trial.
-
Neuropsychiatric Complications of COVID-19.Curr Psychiatry Rep. 2021 Mar 16;23(5):25. doi: 10.1007/s11920-021-01237-9. Curr Psychiatry Rep. 2021. PMID: 33725218 Free PMC article. Review.
-
Evolution of an epidemic: Understanding the opioid epidemic in the United States and the impact of the COVID-19 pandemic on opioid-related mortality.PLoS One. 2024 Jul 9;19(7):e0306395. doi: 10.1371/journal.pone.0306395. eCollection 2024. PLoS One. 2024. PMID: 38980856 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical